<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Patient Prefer Adherence</journal-id><journal-id journal-id-type="iso-abbrev">Patient Prefer Adherence</journal-id><journal-title-group><journal-title>Patient preference and adherence</journal-title></journal-title-group><issn pub-type="epub">1177-889X</issn><publisher><publisher-name>Dove Medical Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24648722</article-id><article-id pub-id-type="pmc">3956685</article-id><article-id pub-id-type="doi">10.2147/PPA.S53617</article-id><article-id pub-id-type="publisher-id">ppa-8-283</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Excessive daytime sleepiness and adherence to antihypertensive medications among Blacks: analysis of the counseling African Americans to control hypertension (CAATCH) trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Williams</surname><given-names>Natasha J</given-names></name><xref ref-type="aff" rid="af1-ppa-8-283">1</xref></contrib><contrib contrib-type="author"><name><surname>Jean-Louis</surname><given-names>Girardin</given-names></name><xref ref-type="aff" rid="af1-ppa-8-283">1</xref><xref ref-type="corresp" rid="c1-ppa-8-283"/></contrib><contrib contrib-type="author"><name><surname>Pandey</surname><given-names>Abhishek</given-names></name><xref ref-type="aff" rid="af2-ppa-8-283">2</xref></contrib><contrib contrib-type="author"><name><surname>Ravenell</surname><given-names>Joseph</given-names></name><xref ref-type="aff" rid="af1-ppa-8-283">1</xref></contrib><contrib contrib-type="author"><name><surname>Boutin-Foster</surname><given-names>Carla</given-names></name><xref ref-type="aff" rid="af3-ppa-8-283">3</xref></contrib><contrib contrib-type="author"><name><surname>Ogedegbe</surname><given-names>Gbenga</given-names></name><xref ref-type="aff" rid="af1-ppa-8-283">1</xref></contrib></contrib-group><aff id="af1-ppa-8-283"><label>1</label>Center for Healthful Behavior Change, Division of Internal Medicine, NYU Medical Center, New York, USA</aff><aff id="af2-ppa-8-283"><label>2</label>Department of Family Medicine, SUNY Downstate Medical Center, Brooklyn, USA</aff><aff id="af3-ppa-8-283"><label>3</label>Center of Excellence in Disparities Research, Weill Cornell Medical College, New York, NY, USA</aff><author-notes><corresp id="c1-ppa-8-283">Correspondence: Girardin Jean-Louis, Center for Healthful Behavior Change, Department of Population Health, New York University School of Medicine, 227 East 30th St, 6th Floor, New York, NY 10016, USA, Tel +1 646 501 2623, Fax +1 212 263 4201, Email <email>girardin.jean-louis@nyumc.org</email></corresp></author-notes><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>11</day><month>3</month><year>2014</year></pub-date><volume>8</volume><fpage>283</fpage><lpage>287</lpage><permissions><copyright-statement>&#x000a9; 2014 Williams et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution &#x02013; Non Commercial (unported, v3.0) License</copyright-statement><copyright-year>2014</copyright-year><license><license-p>The full terms of the License are available at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.</license-p></license></permissions><abstract><sec><title>Background</title><p>Excessive daytime sleepiness (EDS) often occurs as a result of insufficient sleep, sleep apnea, illicit substance use, and other medical and psychiatric conditions. This study tested the hypothesis that blacks exhibiting EDS would have poorer self-reported adherence to hypertensive medication using cross-sectional data from the Counseling African-Americans to Control Hypertension (CAATCH) trial.</p></sec><sec><title>Methods</title><p>A total of 1,058 hypertensive blacks (average age 57&#x000b1;12 years) participated in CAATCH, a randomized controlled trial evaluating the effectiveness of a multilevel intervention for participants who receive care from community health centers in New York City. Data analyzed in this study included baseline sociodemographics, medical history, EDS, and medication adherence. We used the Epworth Sleepiness Scale, with a cutoff score of &#x02265;10, to define EDS. Medication adherence was measured using an abbreviated Morisky Medication Adherence scale, with a score &#x0003e;0 indicating nonadherence.</p></sec><sec><title>Results</title><p>Of the sample, 71% were female, 72% received at least a high school education, 51% reported a history of smoking, and 33% had a history of alcohol consumption. Overall, 27% of the participants exhibited EDS, and 44% of those who exhibited EDS were classified as adherent to prescribed antihypertensive medications. Multivariable logistic regression analysis, adjusting for effects of age, body mass index, sex, education, and smoking and drinking history indicated that participants who exhibited EDS were more than twice as likely to be nonadherent (odds ratio 2.28, 95% confidence interval 1.42&#x02013;3.67, <italic>P</italic>&#x0003c;0.001).</p></sec><sec><title>Conclusion</title><p>Analysis of the CAATCH data showed a high prevalence of EDS among hypertensive blacks. EDS is a significant predictor of nonadherence to prescribed medications for hypertension. These findings point to a modifiable variable that can be targeted in future interventions focusing on medication adherence.</p></sec></abstract><kwd-group><title>Keywords</title><kwd>excessive daytime sleepiness</kwd><kwd>hypertension</kwd><kwd>medication adherence</kwd><kwd>blacks</kwd></kwd-group></article-meta></front><body><sec><title>Introduction</title><p>Hypertension affects more than 70 million people in the US and is one of the leading risk factors for cardiovascular morbidity and mortality.<xref rid="b1-ppa-8-283" ref-type="bibr">1</xref>&#x02013;<xref rid="b3-ppa-8-283" ref-type="bibr">3</xref> Current treatment regimens are effective in controlling hypertension, leading to a decrease in cardiovascular-related events, including stroke and premature death.<xref rid="b1-ppa-8-283" ref-type="bibr">1</xref> According to the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, 69% of hypertensive individuals fail to achieve the recommended blood pressure (BP) goal (&#x0003c;140/90 mmHg).<xref rid="b1-ppa-8-283" ref-type="bibr">1</xref>,<xref rid="b4-ppa-8-283" ref-type="bibr">4</xref> While blacks are prescribed antihypertensive medications at nearly the same rates as non-Hispanic whites, disparities persist in terms of overall disease management. The evidence shows that only 52% of blacks achieve the recommended BP control,<xref rid="b5-ppa-8-283" ref-type="bibr">5</xref> which is closely related to medication adherence. A large, representative, prospective cohort study of adults aged 45 years and older found that blacks had worse medication adherence compared with whites (67.0% versus 33%, <italic>P</italic>&#x0003c;0.0001) using the Morisky Medication Adherence scale.<xref rid="b6-ppa-8-283" ref-type="bibr">6</xref> Together, these findings may explain in part why blacks experience worse cardiovascular health outcomes.</p><p>Several studies have investigated the multifaceted role of patient adherence, including age, socioeconomic status, knowledge, attitudes, beliefs, and perceptions, as well as factors including perceived self-efficacy, patient-provider communication, and access to health care.<xref rid="b7-ppa-8-283" ref-type="bibr">7</xref>&#x02013;<xref rid="b11-ppa-8-283" ref-type="bibr">11</xref> One important but overlooked factor is the role of excessive daytime sleepiness (EDS).</p><p>EDS, the main symptom of sleep-disordered breathing, has been estimated to affect up to 37% of the adult US population.<xref rid="b12-ppa-8-283" ref-type="bibr">12</xref> Importantly, EDS is often chronic, lasting for more than a year in individuals with moderate or severe sleepiness.<xref rid="b13-ppa-8-283" ref-type="bibr">13</xref> It often occurs as a result of insufficient sleep, sleep apnea, illicit substance use, depression, cancer, and other medical conditions.<xref rid="b14-ppa-8-283" ref-type="bibr">14</xref> Of interest is the evidence that supports EDS as an independent risk factor for hypertension.<xref rid="b15-ppa-8-283" ref-type="bibr">15</xref>&#x02013;<xref rid="b19-ppa-8-283" ref-type="bibr">19</xref> Indeed, there is extensive literature on risk factors for daytime sleepiness, including obesity, age, physical activity, and alcohol use,<xref rid="b14-ppa-8-283" ref-type="bibr">14</xref>,<xref rid="b20-ppa-8-283" ref-type="bibr">20</xref> all of which are known risk factors for hypertension. It is plausible that daytime sleepiness could lead to poor medication adherence. To date, no studies have examined the role of EDS in poor medication adherence among hypertensive patients. This is particularly important for blacks, who tend to report inadequate sleep (short and long sleep durations), obstructive sleep apnea, and overall poor sleep quality.<xref rid="b21-ppa-8-283" ref-type="bibr">21</xref>&#x02013;<xref rid="b23-ppa-8-283" ref-type="bibr">23</xref></p><p>Identifying the complex role of medication adherence, particularly in the context of sleep, could prove useful in designing BP control interventions for blacks. In this cross-sectional study, we analyzed data to test the hypothesis that individuals who exhibit EDS would have poorer self-reported adherence to antihypertensive medication. The participants were from the Counseling African Americans to Control Hypertension (CAATCH) trial. The study is registered at <ext-link ext-link-type="uri" xlink:href="http://clinicaltrials.gov">clinicaltrials.gov</ext-link> (NCT00233220).<xref rid="b24-ppa-8-283" ref-type="bibr">24</xref></p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><sec><title>CAATCH trial</title><p>The CAATCH trial is a group randomized control trial comparing a motivational interviewing-based intervention with usual care to improve BP control among hypertensive blacks who receive care in community health care centers. From 2006 to 2009, a total of 1,058 individuals (mean age 46.75&#x000b1;16.23 years) were recruited from 30 community health care centers in the New York City metropolitan area. The community health care centers were eligible if at least 25% of their patients self-identified as black or African-American.<xref rid="b25-ppa-8-283" ref-type="bibr">25</xref> For this secondary data analysis, we focused on baseline sociodemographic and clinical characteristics of CAATCH trial participants. The study methodology and design have been reported previously.<xref rid="b25-ppa-8-283" ref-type="bibr">25</xref></p></sec><sec sec-type="methods"><title>Procedures</title><p>Participants were eligible for the study if they met the following inclusion criteria: self-identify as black or African-American, English speaking, at least 18 years of age, receiving care at a participating community health care center for at least a 6-month period, diagnosis of hypertension and uncontrolled BP at the last office visit (BP &#x02265;140/90 mmHg), taking at least one antihypertensive medication, and having uncontrolled BP (systolic BP &#x02265;140 mmHg or diastolic BP &#x02265;90 mmHg) at the time of consent. BP was measured using an automated oscillometric validated BP monitor (BpTRU&#x000ae;, Smiths Medical MDPM, Waukesha, WI, USA). Excluded from the study were patients who were not fluent in English, had an arm circumference &#x0003e;42 cm, were participating in other hypertension-related trials, were using home BP monitoring, had cognitive impairment as measured by the Mini-Mental State Examination, were unable to complete screening and baseline assessments, and were unwilling or unable to provide written consent. Trained research assistants explained the goals of the study to the participants and obtained baseline clinical and sociodemographic data.<xref rid="b26-ppa-8-283" ref-type="bibr">26</xref></p></sec><sec><title>Measurements</title><sec><title>Daytime sleepiness</title><p>We used the Epworth Sleepiness Scale to assess the severity of daytime sleepiness. This is a self-reported eight-item questionnaire using a Likert-type scale in which the respondent indicates a number ranging from 0 (would never doze or sleep) to 3 (indicating a high chance of dozing or sleeping) based on a given situation including sitting and reading, watching television, or sitting and talking to someone. Respondents who scored greater than 10 would be considered sleepy. Validation studies show satisfactory test-retest reliability (<italic>R</italic>=0.82) and a Cronbach&#x02019;s alpha of 0.88.<xref rid="b27-ppa-8-283" ref-type="bibr">27</xref></p></sec><sec><title>Medication adherence</title><p>Medication adherence was assessed using the Morisky Medication Adherence scale, a validated and reliable measure of adherence to medication.<xref rid="b28-ppa-8-283" ref-type="bibr">28</xref> Participants responded &#x0201c;yes&#x0201d; or &#x0201c;no&#x0201d; to the following questions: Do you ever forget to take your medicine? Are you careless at times about taking your medicine? Do you sometimes stop taking your medicine when you are feeling well? When you feel worse due to the medicine, do you stop taking it? Adherence was measured on a scale of 0 to 4. Respondents who scored greater than 0 would be considered nonadherent. The scale has a Cronbach&#x02019;s alpha of 0.90 and has been used with similar samples.<xref rid="b28-ppa-8-283" ref-type="bibr">28</xref></p></sec></sec><sec sec-type="methods"><title>Statistical analysis</title><p>We used frequency distribution and measures of central tendency to describe sociodemographic factors and the overall health risk profile of the sample. We used multiple logistic regression analysis to assess for an association between EDS and medication adherence, adjusting for effects of age, sex, employment, education, body mass index, and smoking and drinking history. All analyses were conducted using Statistical Package for the Social Sciences version 20 software (SPSS Inc., Armonk, NY, USA). All participants provided written consent and the study was approved by the New York University Medical Center Institutional Review Board.</p></sec></sec><sec sec-type="results"><title>Results</title><p>Of the sample, 71% were female, 72% had received at least a high school education, 51% reported a history of smoking, and 33% reported a history of alcohol consumption. The average participant had a systolic BP of 144&#x000b1;29 mmHg and a diastolic BP of 86&#x000b1;19 mmHg. Mean total cholesterol, triglyceride, and glucose levels were 194&#x000b1;32 mg/dL, 122&#x000b1;71 mg/dL, and 113&#x000b1;48 mg/dL, respectively. Overall, 27% of participants exhibited EDS, and 44% of those who exhibited EDS were classified as being adherent to prescribed antihypertensive medications.</p><p><xref ref-type="table" rid="t1-ppa-8-283">Table 1</xref> shows patient characteristics on the basis of adherence status. There were no significant differences by sex. However, when examining other sociodemographic variables and health risks, we found that those who were adherent were more likely to be employed, have at least a high school education, be less likely to report a history of drinking, but be more likely to report a history of smoking. As shown in <xref ref-type="table" rid="t2-ppa-8-283">Table 2</xref>, our logistic regression analysis indicated that there was a two-fold increase in the odds of being nonadherent among individuals who exhibited EDS (odds ratio 2.28, 95% confidence interval 1.42&#x02013;3.67, <italic>P</italic>&#x0003c;0.001). Of note, age was a significant contributing factor in the model.</p></sec><sec sec-type="discussion"><title>Discussion</title><p>Our study provides evidence of a relationship between EDS and medication adherence in hypertensive blacks. One in four participants exhibited EDS, and individuals who exhibited EDS were nearly twice as likely to be nonadherent. The reported EDS is consistent with other large-scale population studies on the prevalence of EDS in the US population.<xref rid="b12-ppa-8-283" ref-type="bibr">12</xref> Similarly, the adherence rates are consistent with other studies of black hypertensive patients, with nearly one half classified as being nonadherent.<xref rid="b29-ppa-8-283" ref-type="bibr">29</xref></p><p>Our findings are also consistent with a previous study of adult patients with heart failure showing that nonadherence to prescribed medication was significantly higher among individuals who experienced sleepiness using an Epworth cutoff score of &#x02265;6.<xref rid="b30-ppa-8-283" ref-type="bibr">30</xref> The exact mechanisms underlying such associations are not entirely understood. The authors of the aforementioned study concluded that the association between sleepiness and adherence might be explained by cognitive impairment. Cognitive impairment might not have played a significant role in our study, because we included only individuals who were unimpaired. Conceivably, the overall disease burden might be an explanatory factor, given that patients with hypertension often have several comorbid conditions, including diabetes and obesity.<xref rid="b31-ppa-8-283" ref-type="bibr">31</xref> However, we should note that mixed results have been reported, with some studies finding patients with fewer comorbidities are more likely to be adherent, and others finding that patients with a higher number of cardiovascular-related comorbidities are more likely to be adherent.<xref rid="b32-ppa-8-283" ref-type="bibr">32</xref>&#x02013;<xref rid="b34-ppa-8-283" ref-type="bibr">34</xref></p><p>In our analysis, sex was not related to adherence status. In another study utilizing the National Health and Nutrition Examination Survey (1999&#x02013;2004), men had better BP control than non-Hispanic black women (51.1% versus 38.8%).<xref rid="b35-ppa-8-283" ref-type="bibr">35</xref> In addition, results from initial analysis of another study<xref rid="b36-ppa-8-283" ref-type="bibr">36</xref> showed no significant sex-based differences. However, when interactions between sex and education were explored, women with lower education were less likely to be adherent than their male counterparts.<xref rid="b36-ppa-8-283" ref-type="bibr">36</xref></p><p>The results of our study have a number of clinical implications that must be addressed. First, they suggest that health care providers should screen hypertensive patients for sleep-related disorders, particularly EDS. One such screening tool is the Epworth Sleepiness Scale, which is a relatively easy survey that can be self-administered. Other validated self-administered tools are available as well. If necessary, health care providers should organize referral for a sleep study to ascertain the presence of obstructive sleep apnea, a well known independent risk factor for hypertension.<xref rid="b17-ppa-8-283" ref-type="bibr">17</xref>&#x02013;<xref rid="b19-ppa-8-283" ref-type="bibr">19</xref> In either case, this must be done in a culturally and linguistically appropriate manner when targeting minority communities. Second, overall management of hypertension should include newly identified comorbid conditions including sleep-related problems and not solely the traditional conditions like diabetes and chronic kidney disease. Third, behavioral interventions that seek to address adherence status should include adherence to both prescribed sleep and hypertension regimens. Finally, studies may also wish to look at mechanistic factors that may be common to both daytime sleepiness and adherence, such as stress, especially in low-income communities such as the ones sampled in this study.<xref rid="b37-ppa-8-283" ref-type="bibr">37</xref></p><p>Our study has some limitations, including the use of subjective data to measure sleepiness and medication adherence. First, the subjective nature of the data may underestimate the prevalence of EDS, which is a strong predictor of obstructive sleep apnea in this population.<xref rid="b37-ppa-8-283" ref-type="bibr">37</xref>,<xref rid="b38-ppa-8-283" ref-type="bibr">38</xref> However, the data collected in this study do not allow us to determine such associations. Indeed, obstructive sleep apnea is prevalent among hypertensive patients; unique to this report is that sleep-related problems and symptoms in the absence of a sleep disorder could contribute to medication adherence. Second, we used self-reported medication adherence. Future studies should consider valid and reliable objective measures of medication adherence, which could prove useful in obtaining more accurate assessments.<xref rid="b11-ppa-8-283" ref-type="bibr">11</xref> Finally, the findings are limited to a specific population, ie, low-income blacks, so are not representative of the entire US adult population. Despite these limitations, we believe that our findings add to the growing body of literature linking sleep and hypertension.</p></sec><sec><title>Conclusion</title><p>Overall, patient nonadherence continues to represent a significant public health burden. Our findings suggest that multifaceted and innovative interventions coupled with traditional risk factors could facilitate medication adherence among blacks.</p></sec></body><back><ack><title>Acknowledgments</title><p>This research was supported by funding from the National Institutes of Health (R25HL105444, K24HL111315, R01HL095799, and R01MD004113).</p></ack><fn-group><fn><p><bold>Disclosure</bold></p><p>The authors report no conflicts of interest in this work.</p></fn></fn-group><ref-list><title>References</title><ref id="b1-ppa-8-283"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chobanian</surname><given-names>AV</given-names></name><name><surname>Bakris</surname><given-names>GL</given-names></name><name><surname>Black</surname><given-names>HR</given-names></name><etal/></person-group><article-title>The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure</article-title><source>Hypertension</source><year>2003</year><volume>42</volume><issue>6</issue><fpage>1206</fpage><lpage>1252</lpage><pub-id pub-id-type="pmid">14656957</pub-id></element-citation></ref><ref id="b2-ppa-8-283"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGruder</surname><given-names>HF</given-names></name><name><surname>Malarcher</surname><given-names>AM</given-names></name><name><surname>Antoine</surname><given-names>TL</given-names></name><etal/></person-group><article-title>Racial and ethnic disparities in cardiovascular risk factors among stroke survivors &#x02013; United States</article-title><source>Stroke</source><year>2004</year><volume>35</volume><issue>7</issue><fpage>1557</fpage><lpage>1561</lpage><pub-id pub-id-type="pmid">15192252</pub-id></element-citation></ref><ref id="b3-ppa-8-283"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollar</surname><given-names>D</given-names></name><name><surname>Agatston</surname><given-names>AS</given-names></name><name><surname>Hennekens</surname><given-names>CH</given-names></name></person-group><article-title>Hypertension: trends, risks, drug therapies and clinical challenges in African Americans</article-title><source>Ethn Dis</source><year>2004</year><volume>14</volume><issue>4</issue><fpage>S23</fpage><lpage>S25</lpage></element-citation></ref><ref id="b4-ppa-8-283"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>QP</given-names></name><name><surname>Burt</surname><given-names>VL</given-names></name><name><surname>Paulose-Ram</surname><given-names>R</given-names></name><etal/></person-group><article-title>High blood pressure and cardiovascular disease mortality risk among US adults: the Third National Health and Nutrition Examination Survey mortality follow-up study</article-title><source>Ann Epidemiol</source><year>2008</year><volume>18</volume><issue>4</issue><fpage>302</fpage><lpage>309</lpage><pub-id pub-id-type="pmid">18261929</pub-id></element-citation></ref><ref id="b5-ppa-8-283"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>Q</given-names></name><name><surname>Burt</surname><given-names>VL</given-names></name><name><surname>Dillon</surname><given-names>CF</given-names></name><etal/></person-group><article-title>Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health and Nutrition Examination Survey, 2001 to 2010</article-title><source>Circulation</source><year>2012</year><volume>126</volume><issue>17</issue><fpage>2105</fpage><lpage>2114</lpage><pub-id pub-id-type="pmid">23091084</pub-id></element-citation></ref><ref id="b6-ppa-8-283"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muntner</surname><given-names>P</given-names></name><name><surname>Halanychi</surname><given-names>J</given-names></name><name><surname>Reynolds</surname><given-names>K</given-names></name><etal/></person-group><article-title>Low medication adherence and the incidence of stroke symptoms among individuals with hypertension: the REGARDS study</article-title><source>J Clin Hypertens</source><year>2011</year><volume>13</volume><issue>7</issue><fpage>479</fpage><lpage>486</lpage></element-citation></ref><ref id="b7-ppa-8-283"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>J</given-names></name><name><surname>Muntner</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><etal/></person-group><article-title>Factors associated with hypertension control in the general population of the United States</article-title><source>Arch Intern Med</source><year>2002</year><volume>162</volume><issue>9</issue><fpage>1051</fpage><lpage>1058</lpage><pub-id pub-id-type="pmid">11996617</pub-id></element-citation></ref><ref id="b8-ppa-8-283"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charles</surname><given-names>H</given-names></name><name><surname>Good</surname><given-names>CB</given-names></name><name><surname>Hanusa</surname><given-names>BH</given-names></name><name><surname>Chang</surname><given-names>CCH</given-names></name><name><surname>Whittle</surname><given-names>J</given-names></name></person-group><article-title>Racial differences in adherence to cardiac medications</article-title><source>J Natl Med Assoc</source><year>2003</year><volume>95</volume><issue>1</issue><fpage>17</fpage><pub-id pub-id-type="pmid">12656446</pub-id></element-citation></ref><ref id="b9-ppa-8-283"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogedegbe</surname><given-names>G</given-names></name><name><surname>Schoenthaler</surname><given-names>A</given-names></name><name><surname>Richardson</surname><given-names>T</given-names></name><etal/></person-group><article-title>An RCT of the effect of motivational interviewing on medication adherence in hypertensive African Americans: rationale and design</article-title><source>Contemp Clin Trials</source><year>2007</year><volume>28</volume><issue>2</issue><fpage>169</fpage><lpage>181</lpage><pub-id pub-id-type="pmid">16765100</pub-id></element-citation></ref><ref id="b10-ppa-8-283"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>BJ</given-names></name><name><surname>Hollenbeak</surname><given-names>C</given-names></name><name><surname>Weiner</surname><given-names>MG</given-names></name><etal/></person-group><article-title>Barriers to adherence and hypertension control in a racially diverse representative sample of elderly primary care patients</article-title><source>Pharmacoepidemiol Drug Saf</source><year>2009</year><volume>18</volume><issue>8</issue><fpage>672</fpage><lpage>681</lpage><pub-id pub-id-type="pmid">19479901</pub-id></element-citation></ref><ref id="b11-ppa-8-283"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>LM</given-names></name></person-group><article-title>Factors associated with medication adherence in hypertensive blacks: a review of the literature</article-title><source>J Cardiovasc Nurs</source><year>2012</year><volume>27</volume><issue>3</issue><fpage>208</fpage><lpage>219</lpage><pub-id pub-id-type="pmid">21760525</pub-id></element-citation></ref><ref id="b12-ppa-8-283"><label>12</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>National Sleep Foundation</collab></person-group><source>Excessive Daytime Sleepiness, Health, and Safety</source><publisher-name>Sleep Foundation</publisher-name><year>2010</year><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.sleepfoundation.org">http://www.sleepfoundation.org</ext-link></comment><date-in-citation>Accessed November 18, 2012</date-in-citation></element-citation></ref><ref id="b13-ppa-8-283"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohayon</surname><given-names>MM</given-names></name></person-group><article-title>Detrimental effects of double occupation on the sleep of students</article-title><source>Sleep</source><year>2011</year><volume>34</volume><fpage>A184</fpage></element-citation></ref><ref id="b14-ppa-8-283"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pagel</surname><given-names>JF</given-names></name></person-group><article-title>Excessive daytime sleepiness</article-title><source>Am Fam Physician</source><year>2009</year><volume>79</volume><issue>5</issue><fpage>391</fpage><lpage>396</lpage><pub-id pub-id-type="pmid">19275068</pub-id></element-citation></ref><ref id="b15-ppa-8-283"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>AB</given-names></name><name><surname>Spiekerman</surname><given-names>CF</given-names></name><name><surname>Enright</surname><given-names>P</given-names></name><etal/></person-group><article-title>Daytime sleepiness mortality and cardiovascular disease in older adults</article-title><source>J Am Geriatr Soc</source><year>2000</year><volume>48</volume><issue>2</issue><fpage>115</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">10682939</pub-id></element-citation></ref><ref id="b16-ppa-8-283"><label>16</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Colten</surname><given-names>HR</given-names></name><name><surname>Altevogt</surname><given-names>BM</given-names></name></person-group><source>Sleep Disorders And Sleep Deprivation: An Unmet Public Health Problem</source><publisher-loc>Washington DC</publisher-loc><publisher-name>National Academies Press</publisher-name><year>2006</year></element-citation></ref><ref id="b17-ppa-8-283"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohayon</surname><given-names>MM</given-names></name><name><surname>Guilleminault</surname><given-names>C</given-names></name><name><surname>Priest</surname><given-names>RG</given-names></name><name><surname>Zulley</surname><given-names>J</given-names></name><name><surname>Smirne</surname><given-names>S</given-names></name></person-group><article-title>Is sleep-disordered breathing an independent risk factor for hypertension in the general population?</article-title><source>J Psychosom Res</source><year>2000</year><volume>48</volume><issue>6</issue><fpage>593</fpage><lpage>601</lpage><pub-id pub-id-type="pmid">11033380</pub-id></element-citation></ref><ref id="b18-ppa-8-283"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lavie</surname><given-names>P</given-names></name><name><surname>Herer</surname><given-names>P</given-names></name><name><surname>Hoffstein</surname><given-names>V</given-names></name></person-group><article-title>Obstructive sleep apnea syndrome as a risk factor for hypertension: population study</article-title><source>BMJ</source><year>2000</year><volume>320</volume><issue>7233</issue><fpage>479</fpage><lpage>482</lpage><pub-id pub-id-type="pmid">10678860</pub-id></element-citation></ref><ref id="b19-ppa-8-283"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>T</given-names></name><name><surname>Peppard</surname><given-names>P</given-names></name><name><surname>Palta</surname><given-names>M</given-names></name><etal/></person-group><article-title>Population-based study of sleep-disordered breathing as a risk factor for hypertension</article-title><source>Arch Intern Med</source><year>1997</year><volume>157</volume><issue>15</issue><fpage>1746</fpage><lpage>1752</lpage><pub-id pub-id-type="pmid">9250236</pub-id></element-citation></ref><ref id="b20-ppa-8-283"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bixler</surname><given-names>EO</given-names></name><name><surname>Vgontzas</surname><given-names>AN</given-names></name><name><surname>Lin</surname><given-names>HM</given-names></name><etal/></person-group><article-title>Excessive daytime sleepiness in a general population sample: the role of sleep apnoea, age, obesity, diabetes, and depression</article-title><source>J Clin Endocrinol Metab</source><year>2005</year><volume>90</volume><issue>8</issue><fpage>4510</fpage><lpage>4515</lpage><pub-id pub-id-type="pmid">15941867</pub-id></element-citation></ref><ref id="b21-ppa-8-283"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zizi</surname><given-names>F</given-names></name><name><surname>Pandey</surname><given-names>A</given-names></name><name><surname>Murray-Bachmann</surname><given-names>R</given-names></name><etal/></person-group><article-title>Race/ethnicity, sleep duration, and diabetes mellitus: analysis of the National Health Interview Survey</article-title><source>Am J Med</source><year>2012</year><volume>125</volume><issue>2</issue><fpage>162</fpage><lpage>167</lpage><pub-id pub-id-type="pmid">22269619</pub-id></element-citation></ref><ref id="b22-ppa-8-283"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durrence</surname><given-names>HH</given-names></name><name><surname>Lichstein</surname><given-names>LK</given-names></name></person-group><article-title>The sleep of African Americans: a comparative review</article-title><source>Behav Sleep Med</source><year>2006</year><volume>4</volume><issue>1</issue><fpage>29</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">16390283</pub-id></element-citation></ref><ref id="b23-ppa-8-283"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Redline</surname><given-names>S</given-names></name><name><surname>Tishler</surname><given-names>PV</given-names></name><name><surname>Hans</surname><given-names>MG</given-names></name><name><surname>Tosteson</surname><given-names>TD</given-names></name><name><surname>Strohl</surname><given-names>KP</given-names></name><name><surname>Spry</surname><given-names>K</given-names></name></person-group><article-title>Racial differences in sleep-disordered breathing in African-Americans and Caucasians</article-title><source>Am J Respir Crit Care Med</source><year>1997</year><volume>155</volume><issue>1</issue><fpage>186</fpage><lpage>192</lpage><pub-id pub-id-type="pmid">9001310</pub-id></element-citation></ref><ref id="b24-ppa-8-283"><label>24</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>National Heart, Lung, and Blood Institute (NHLBI)</collab></person-group><source>The recruitment status of this study is unknown because the information has not been verified recently</source><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://clinicaltrials.gov/show/NCT00233220">http://clinicaltrials.gov/show/NCT00233220</ext-link>. NLM identifier: NCT00233220</comment><date-in-citation>Accessed November 1, 2013</date-in-citation></element-citation></ref><ref id="b25-ppa-8-283"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogedegbe</surname><given-names>G</given-names></name><name><surname>Tobin</surname><given-names>JN</given-names></name><name><surname>Fernandez</surname><given-names>S</given-names></name><etal/></person-group><article-title>Counseling African Americans to control hypertension (CAATCH) trial: a multi-level intervention to improve blood pressure control in hypertensive blacks</article-title><source>Circ Cardiovasc Qual Outcomes</source><year>2009</year><volume>2</volume><issue>3</issue><fpage>249</fpage><lpage>256</lpage><pub-id pub-id-type="pmid">20031845</pub-id></element-citation></ref><ref id="b26-ppa-8-283"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schoenthaler</surname><given-names>A</given-names></name><name><surname>Allegrante</surname><given-names>J</given-names></name><name><surname>Chaplin</surname><given-names>W</given-names></name><name><surname>Ogedegbe</surname><given-names>G</given-names></name></person-group><article-title>The effect of patient-provider communication on medication adherence in hypertensive black patients: does race concordance matter?</article-title><source>Ann Behav Med</source><year>2012</year><volume>43</volume><issue>3</issue><fpage>372</fpage><lpage>382</lpage><pub-id pub-id-type="pmid">22270266</pub-id></element-citation></ref><ref id="b27-ppa-8-283"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johns</surname><given-names>MW</given-names></name></person-group><article-title>Reliability and factor-analysis of the Epworth Sleepiness Scale</article-title><source>Sleep</source><year>1992</year><volume>15</volume><issue>4</issue><fpage>376</fpage><lpage>381</lpage><pub-id pub-id-type="pmid">1519015</pub-id></element-citation></ref><ref id="b28-ppa-8-283"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morisky</surname><given-names>DE</given-names></name><name><surname>Green</surname><given-names>LW</given-names></name><name><surname>Levine</surname><given-names>DM</given-names></name></person-group><article-title>Concurrent and predictive validity of a self-reported measure of medication adherence</article-title><source>Med Care</source><year>1986</year><volume>24</volume><issue>1</issue><fpage>67</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">3945130</pub-id></element-citation></ref><ref id="b29-ppa-8-283"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez</surname><given-names>S</given-names></name><name><surname>Tobin</surname><given-names>J</given-names></name><name><surname>Cassells</surname><given-names>A</given-names></name><name><surname>Diaz-Gloster</surname><given-names>M</given-names></name><name><surname>Kalida</surname><given-names>C</given-names></name><name><surname>Ogedegbe</surname><given-names>G</given-names></name></person-group><article-title>The counseling African Americans to control hypertension (CAATCH) trial: baseline demographic, clinical, psychosocial, and behavioral characteristics</article-title><source>Implement Sci</source><year>2011</year><volume>6</volume><fpage>100</fpage><pub-id pub-id-type="pmid">21884616</pub-id></element-citation></ref><ref id="b30-ppa-8-283"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riegel</surname><given-names>B</given-names></name><name><surname>Moelter</surname><given-names>S</given-names></name><name><surname>Ratcliffe</surname><given-names>S</given-names></name><etal/></person-group><article-title>Excessive daytime sleepiness is associated with poor medication adherence in adults with heart failure</article-title><source>J Card Fail</source><year>2011</year><volume>17</volume><issue>4</issue><fpage>340</fpage><lpage>348</lpage><pub-id pub-id-type="pmid">21440873</pub-id></element-citation></ref><ref id="b31-ppa-8-283"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schoenthaler</surname><given-names>A</given-names></name><name><surname>Ogedegbe</surname><given-names>G</given-names></name><name><surname>Allegrante</surname><given-names>JP</given-names></name></person-group><article-title>Self-efficacy mediates the relationship between depressive symptoms and medication adherence among hypertensive African Americans</article-title><source>Health Educ Behav</source><year>2007</year><volume>36</volume><issue>1</issue><fpage>127</fpage><lpage>137</lpage><pub-id pub-id-type="pmid">18077654</pub-id></element-citation></ref><ref id="b32-ppa-8-283"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lagu</surname><given-names>T</given-names></name><name><surname>Weiner</surname><given-names>MG</given-names></name><name><surname>Eachus</surname><given-names>S</given-names></name><name><surname>Tang</surname><given-names>SSK</given-names></name><name><surname>Schwartz</surname><given-names>JS</given-names></name><name><surname>Turner</surname><given-names>BJ</given-names></name></person-group><article-title>Effect of patient comorbidities on filling of antihypertensive prescriptions</article-title><source>Am J Manag Care</source><year>2009</year><volume>15</volume><issue>1</issue><fpage>24</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">19146361</pub-id></element-citation></ref><ref id="b33-ppa-8-283"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schoenthaler</surname><given-names>A</given-names></name><name><surname>Chaplin</surname><given-names>WF</given-names></name><name><surname>Allegrante</surname><given-names>JP</given-names></name><etal/></person-group><article-title>Provider communication effects medication adherence in hypertensive African Americans</article-title><source>Patient Educ Couns</source><year>2009</year><volume>75</volume><issue>2</issue><fpage>185</fpage><lpage>191</lpage><pub-id pub-id-type="pmid">19013740</pub-id></element-citation></ref><ref id="b34-ppa-8-283"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>Q</given-names></name><name><surname>Burt</surname><given-names>VL</given-names></name><name><surname>Paulose-Ram</surname><given-names>R</given-names></name><name><surname>Dillon</surname><given-names>CF</given-names></name></person-group><article-title>Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999&#x02013;2004</article-title><source>Am J Hypertens</source><year>2008</year><volume>21</volume><issue>7</issue><fpage>789</fpage><lpage>798</lpage><pub-id pub-id-type="pmid">18451806</pub-id></element-citation></ref><ref id="b35-ppa-8-283"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braveman</surname><given-names>J</given-names></name><name><surname>Dedier</surname><given-names>J</given-names></name></person-group><article-title>Predictors of medication adherence for African American patients diagnosed with hypertension</article-title><source>Ethn Dis</source><year>2009</year><volume>19</volume><issue>4</issue><fpage>396</fpage><lpage>400</lpage><pub-id pub-id-type="pmid">20073139</pub-id></element-citation></ref><ref id="b36-ppa-8-283"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kashani</surname><given-names>M</given-names></name><name><surname>Eliasson</surname><given-names>A</given-names></name><name><surname>Vernalis</surname><given-names>M</given-names></name></person-group><article-title>Perceived stress correlates with disturbed sleep: a link connecting stress and cardiovascular disease</article-title><source>Stress</source><year>2012</year><volume>15</volume><issue>1</issue><fpage>45</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">21682656</pub-id></element-citation></ref><ref id="b37-ppa-8-283"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strohl</surname><given-names>KP</given-names></name><name><surname>Redline</surname><given-names>S</given-names></name></person-group><article-title>Recognition of obstructive sleep apnea</article-title><source>Am J Respir Crit Care Med</source><year>1996</year><volume>154</volume><issue>2 Pt 1</issue><fpage>279</fpage><lpage>289</lpage><pub-id pub-id-type="pmid">8756795</pub-id></element-citation></ref><ref id="b38-ppa-8-283"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jean-Louis</surname><given-names>G</given-names></name><name><surname>Magai</surname><given-names>CM</given-names></name><name><surname>Cohen</surname><given-names>CI</given-names></name><etal/></person-group><article-title>Ethnic differences in self-reported sleep problems in older adults</article-title><source>Sleep</source><year>2001</year><volume>24</volume><issue>8</issue><fpage>926</fpage><lpage>933</lpage><pub-id pub-id-type="pmid">11766163</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="t1-ppa-8-283" position="float"><label>Table 1</label><caption><p>Adherence status by sociodemographic characteristics and health risks</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="2" colspan="1">Variable</th><th colspan="2" align="left" valign="top" rowspan="1">Adherence status
<hr/></th><th align="left" valign="top" rowspan="2" colspan="1"><italic>P</italic> value</th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1">Adherent</th><th align="left" valign="top" rowspan="1" colspan="1">Nonadherent</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Age (mean &#x000b1; SD)</td><td align="left" valign="top" rowspan="1" colspan="1">55&#x000b1;12</td><td align="left" valign="top" rowspan="1" colspan="1">60&#x000b1;11</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BMI (mean &#x000b1; SD)</td><td align="left" valign="top" rowspan="1" colspan="1">34&#x000b1;8</td><td align="left" valign="top" rowspan="1" colspan="1">32&#x000b1;6</td><td align="left" valign="top" rowspan="1" colspan="1">0.004</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Female sex %</td><td align="left" valign="top" rowspan="1" colspan="1">72</td><td align="left" valign="top" rowspan="1" colspan="1">72</td><td align="left" valign="top" rowspan="1" colspan="1">0.800</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Employed %</td><td align="left" valign="top" rowspan="1" colspan="1">39</td><td align="left" valign="top" rowspan="1" colspan="1">28</td><td align="left" valign="top" rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02265;high school %</td><td align="left" valign="top" rowspan="1" colspan="1">37</td><td align="left" valign="top" rowspan="1" colspan="1">38</td><td align="left" valign="top" rowspan="1" colspan="1">0.017</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Alcohol history %</td><td align="left" valign="top" rowspan="1" colspan="1">37</td><td align="left" valign="top" rowspan="1" colspan="1">26</td><td align="left" valign="top" rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Smoking history %</td><td align="left" valign="top" rowspan="1" colspan="1">55</td><td align="left" valign="top" rowspan="1" colspan="1">46</td><td align="left" valign="top" rowspan="1" colspan="1">0.008</td></tr></tbody></table><table-wrap-foot><fn id="tfn1-ppa-8-283"><p><bold>Note:</bold> Mean &#x000b1; SD and (%) is reported.</p></fn><fn id="tfn2-ppa-8-283"><p><bold>Abbreviations:</bold> BMI, body mass index; SD, standard deviation.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2-ppa-8-283" position="float"><label>Table 2</label><caption><p>Associations of sociodemographic characteristics and risk factors with EDS and adherence</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Variable</th><th align="left" valign="top" rowspan="1" colspan="1">OR</th><th align="left" valign="top" rowspan="1" colspan="1">CI</th><th align="left" valign="top" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Sleepy</td><td align="left" valign="top" rowspan="1" colspan="1">2.28</td><td align="left" valign="top" rowspan="1" colspan="1">1.42&#x02013;3.67</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Age</td><td align="left" valign="top" rowspan="1" colspan="1">0.97</td><td align="left" valign="top" rowspan="1" colspan="1">0.95&#x02013;0.99</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BMI</td><td align="left" valign="top" rowspan="1" colspan="1">1.02</td><td align="left" valign="top" rowspan="1" colspan="1">1.00&#x02013;1.10</td><td align="left" valign="top" rowspan="1" colspan="1">0.110</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sex</td><td align="left" valign="top" rowspan="1" colspan="1">1.13</td><td align="left" valign="top" rowspan="1" colspan="1">0.71&#x02013;1.80</td><td align="left" valign="top" rowspan="1" colspan="1">0.606</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Employed</td><td align="left" valign="top" rowspan="1" colspan="1">1.41</td><td align="left" valign="top" rowspan="1" colspan="1">0.90&#x02013;2.22</td><td align="left" valign="top" rowspan="1" colspan="1">0.140</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Education</td><td align="left" valign="top" rowspan="1" colspan="1">0.92</td><td align="left" valign="top" rowspan="1" colspan="1">0.75&#x02013;1.06</td><td align="left" valign="top" rowspan="1" colspan="1">0.205</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Alcohol use</td><td align="left" valign="top" rowspan="1" colspan="1">1.29</td><td align="left" valign="top" rowspan="1" colspan="1">0.74&#x02013;1.90</td><td align="left" valign="top" rowspan="1" colspan="1">0.468</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Smoking</td><td align="left" valign="top" rowspan="1" colspan="1">1.34</td><td align="left" valign="top" rowspan="1" colspan="1">0.86&#x02013;2.10</td><td align="left" valign="top" rowspan="1" colspan="1">0.195</td></tr></tbody></table><table-wrap-foot><fn id="tfn3-ppa-8-283"><p><bold>Abbreviations:</bold> BMI, body mass index; EDS, excessive daytime sleepiness; OR, odds ratio, CI, confidence interval.</p></fn></table-wrap-foot></table-wrap></floats-group></article>